Study Provides Details on Death With Dignity Act Utilization, Efficacy
In Oregon, the number of physician-aided dying prescriptions has increased annually since the passing of the state’s Death with Dignity Act in 1997.
Dermoscopic Evaluation of Seborrheic Keratosis Can Help Diagnose Melanoma
A study has identified several characteristics that can help detect seborrheic keratosis–like melanomas using dermoscopy, which can help to diagnose melanoma.
Survival Worse in Patients With Rare Oropharyngeal Small-Cell Carcinoma
Oropharyngeal small-cell carcinoma was more likely to present as distant disease and was associated with worse survival outcomes compared with squamous cell carcinoma, according to new research.
Adjuvant Chemotherapy Less Likely in Elderly Stage III Colon Cancer Patients
Adjuvant chemotherapy is underutilized in elderly patients with stage III colon cancer, despite improved long-term survival after treatment.
Immunotherapy Combination Promising in Advanced Melanoma
The combination of an intratumoral injection of CVA21 and ipilimumab has demonstrated durable response with minimal toxicity in patients with advanced melanoma.
Low Disease Burden Improved Durability of CAR T-Cell Therapy in B-ALL
Low pretreatment disease burden improved durability of CAR T-cell therapy in patients with relapsed B-cell acute lymphoblastic leukemia.
Smoking Linked With Worse Pancreatic Cancer Survival
Cigarette smoking was associated with an almost 40% reduction in survival among patients with pancreatic cancer.
Adiponectin Signaling May Explain “Obesity Paradox” of RCC
BMI was inversely correlated with serum adiponectin levels in RCC, and low BMI and high adiponectin might be associated with disease aggressiveness and survival in patients with the disease.
Pacritinib Induced Reduction in Splenomegaly, Myelofibrosis Symptoms
The JAK2 and FLT3 inhibitor pacritinib induced significant and sustained spleen volume reduction and symptom reduction in patients with myelofibrosis.
Relapsed, Refractory Myeloma Has Indirect Societal Costs
Patients with relapsed or refractory multiple myeloma experienced significant indirect social costs from their disease, in addition to the direct costs.
By clicking Accept, you agree to become a member of the UBM Medica Community.